You are here
TGA Internet site archive
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
Consultation: Medicine label advisory statements
Related information
- Required advisory statements for medicine labels, published in the Commonwealth of Australia Gazette, No. GN 25, 23 June 2004
13 December 2002
This paper was released in November 2002 for comment. It remains on this website as a historical reference.
The TGA's Review of the Labelling Requirements for Medicines recommended that warning and advisory statements from various sources (such as the Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP) and the Therapeutic Goods Regulations) be consolidated into a single document.
This consultation document proposes a method for implementing that recommendation and a process for ensuring the resulting document is maintained in an efficient and effective manner.
Medicine label advisory statements - consultation document (pdf,59kb)
Contents
- Background
- Guiding principles
- Part A Transfer of advisory statements
- What is being proposed
- Legislative change
- Timetable for the transfer
- Effect/impact of the proposal
- Benefits of the proposal
- Questions and answers
- Part B Updating and maintenance of required advisory statements for therapeutic goods
- Overview
- Changing advisory statements
- Questions and answers
- Attachment 1: Addition/amendment of a label advisory statement